Audet Juliette Berangere
SEC CIK 2000393 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma Co N.V. | Chief Business Off | 15.1K | $17.3K | — | 2 | 2024-09-26 | 2025-01-07 |
Most active insiders at NAMS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Davidson Michael H. | CEO, Dir | $226.5K | $25.33M |
| 2 | Kooij Louise Frederika | CAO | — | $16.75M |
| 3 | Kastelein Johannes Jacob Pieter | CSO, Dir | — | $14.26M |
| 4 | Somaiya Mayur Ian | CFO | — | $3.43M |
| 5 | LANGE LOUIS G | Dir | — | $2.19M |
| 6 | Smither John W | Dir | — | $40.5K |
| 7 | Gunning Robert William | VP, Ctrl | — | — |
| 8 | van der Kamp Hilde Johanna | Dir | — | — |
| 9 | McKenna Mark C. | Dir | — | — |
| 10 | Gulfo Adele M. | Dir | — | — |
Audet Juliette Berangere made no open-market trades at NAMS in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-07 | 2025-01-07 | NAMS | NewAmsterdam Pharma Co N.V. | Audet Juliette Berangere | Chief Business Off | A - Grant | — | +14.0K | 15.1K | +1,268% | — | |
| 2024-09-30 | 2024-09-26 | NAMS | NewAmsterdam Pharma Co N.V. | Audet Juliette Berangere | Chief Business Off | P - Purchase | $15.70 | +1,104 | 1,104 | New | +$17.3K |
Purchase Sale Sale after option exercise All abbreviations